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ABSTRACT 
Azaspiracids (AZA) are polyether marine toxins of dinoflagellate origin that accumulate in 
shellfish and represent an emerging human health risk. Although monitored and regulated in 
many European and Asian countries, there are no monitoring programs or regulatory 
requirements in the United States for this toxin group. This did not prove to be a problem until 
June 2009 when AZAs were identified in US seafood for the first time resulting in human 
intoxications and further expanding their global distribution. Efforts are now underway in several 
laboratories to better define the effects and mechanism(s) of action for the AZAs. Our 
investigations have employed Jurkat T lymphocyte cells as an in vitro model to characterize the 
toxicological effects of AZA1, AZA2, and AZA3. Cytotoxicity experiments employing a 
metabolically-based dye (i.e., MTS) indicated that AZA1, AZA2, and AZA3 each elicited a 
lethal response that was both concentration- and time- dependent, with EC50 values in the sub- to 
low nanomolar range. Based on EC50 comparisons, the order of potency was as follows: AZA2 > 
AZA3 > AZA1, with toxic equivalence factors (TEFs) relative to AZA1 of 8.3-fold and 4.5-fold 
greater for AZA2 and AZA3, respectively. Image analysis of exposed cells using Nomarski 
differential interference contrast (DIC) imaging and fluorescent imaging of cellular actin 
indicated that the morphological effects of AZA1 on this cell type are unique relative to the 
effects of AZA2 and AZA3. Collectively, our data support the growing body of evidence 
suggesting that natural analogs of AZA are highly potent and that they may have multiple 
molecular targets.  
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INTRODUCTION 
Azaspiracids (AZAs) are a class of polyether marine toxins produced by the marine 
dinoflagellate Azadinium spinosum (1). AZA toxins were originally found in shellfish off the 
coast of Ireland and have caused multiple human intoxication events throughout Europe 
(reviewed by Furey et al. (2)) and most recently in the United States (3). Reports of Azadinium 
species and/or AZAs have now been documented for many other parts of the world, including 
Morocco (4), Chile (5), and Canada (M. Quilliam, pers. comm). AZAs were also recently 
detected in marine sponges (6). Human symptoms following intoxication include nausea, 
vomiting, and stomach cramps (7), but thus far no deaths have been attributed to AZAs.  
The AZA group now includes more than 20 analogs that are produced either by phytoplankton, 
through biotransformation in shellfish, or as by-products formed during processing and storage 
of toxin-containing tissues (7-9). Although there is geographical variation, plankton samples are 
dominated by AZA1 and AZA2 (Figure 1), with the former often constituting over 80% of the 
toxin profile (1, 10). The recent isolation and culturing of A. spinosum has further confirmed 
these findings (1, 11), but interestingly, other non-toxigenic Azadinium species have now been 
described (12). Naturally contaminated shellfish often remain above the European regulatory 
action level for many months following exposure to AZAs (13, 14). Toxin binding proteins may 
be responsible, in part, for this slow rate of depuration in certain shellfish (15, 16). 
Studies in mice exposed orally to AZA1 revealed severe gastrointestinal tract deterioration, 
adverse histopathologies of the liver, spleen, and thymus, as well as a small incidence of tumor 
formation (17, 18). The minimal lethal doses for AZA1 are ca. 500 µg/kg (oral) (19) and ca. 150 
µg/kg (i.p.) (20). Relative analog potencies (via i.p.) are as follows: AZA2 > AZA3 > AZA1 > 
AZA4 > AZA5 (7, 21, 22). Note that AZA4 and AZA5 are the 3- and 23-hydroxyl analogs, 
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respectively, of AZA3. Although these experimental data are extremely valuable, their clear 
interpretation has been hindered due to the use of material of unknown purity. Nonetheless, this 
information has provided the guidance needed to propose toxic equivalence factors (TEFs) (1.0, 
1.8, and 1.4 for AZA1, AZA2, and AZA3; respectively) that are used for determining the total 
AZA equivalent concentrations in European shellfish (23).  The EU regulatory limit is 0.16 µg/g 
“total” AZAs in shellfish as detected by LC-MS/MS. Only AZA1-3 are currently regulated.  
Multiple studies have demonstrated the in vitro cytotoxic potential of AZA1 wherein every cell 
type tested to date appears to be susceptible (see Twiner et al. (7) for a review). AZAs are very 
potent cytotoxic compounds (6, 24, 25), induce irreversible cytoskeletal rearrangements in 
mammalian cells (24, 26, 27), stimulate secondary messenger molecules (28, 29), deplete 
cellular ATP (30), inhibit neuronal ion flux and bioelectrical activity (31, 32), induce cell volume 
reductions followed by c-Jun N-terminal kinase (JNK) activation (33, 34), inhibit membrane 
protein endocytosis (35), and up-regulate low density lipoprotein receptor as well as stimulating 
cholesterol biosynthesis (36). AZA1 has also been shown to be a potent teratogen in developing 
fish embryos (37). In many cases the toxin concentrations necessary to observe these various 
effects are in the low nanomolar range (7, 31, 34, 35), but for some endpoints they approach or 
exceed micromolar concentrations (31, 38). Despite the efforts of many investigators, the 
mechanism(s) of action of AZAs has not yet been determined. 
The possible involvement of an apoptotic pathway in AZA1 cytotoxicity is complicated and 
remains unresolved. Results of an in vitro study assessing mitochrondrial membrane potential in 
neuroblastoma cells (38) are suggestive of a non-apoptotic pathway; however, up-regulation of 
caspase activity in neuroblastoma cells (39) and neocortical neurons (31) is supportive of 
apoptosis activation. Furthermore, apoptotic lymphocyte cells have been observed in the spleens 
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of mice exposed to AZA1 (40). Nonetheless, such discrepancies may be explained, in part, by 
AZA1 causing simultaneous induction of both necrotic and apoptotic mechanisms (31). 
Due to difficulties in obtaining sufficient amounts of purified material, much less information 
is available regarding the toxicological properties of the other natural AZA analogs. At relatively 
high concentrations (i.e., 50-1000 nM), AZA2, AZA3, AZA4, and AZA5 have been shown to 
have various effects on intracellular pH, cytosolic calcium, and cAMP in lymphocytes (29, 41, 
42). In neocortical neurons, AZA1, AZA2, and AZA3 inhibited spontaneous Ca2+ oscillations at 
moderate concentrations (EC50 values ranged from 138 to 445 nM), with 48 h cytotoxicity EC50 
values of 43, 48, and 10 nM, respectively (31). This study provided the first side-by-side 
evidence for potency differences among these regulated toxins.    
Clearly, structure-activity relationship (SAR) studies are very important from a regulatory 
perspective, but to date, have been hindered by the lack of pure material. As such, many of the 
previous SAR studies have been confined to the study of AZA1 and its synthetic fragments (43, 
44); however, purified AZA2 and AZA3 have recently become available commercially (45). 
This supply of new material enabled the present comparative study in which we characterized the 
toxicological effects of the currently regulated AZAs (i.e., AZA1, AZA2, AZA3) in an in vitro 
model system based on the Jurkat T lymphocyte cell line.  
 
MATERIALS AND METHODS 
Toxin Isolation. AZA1, AZA2 and AZA3 were isolated from whole cooked mussel tissue (M. 
edulis) collected in 2005 from Bruckless, Donegal, Ireland. The toxins were purified using a 7 
step isolation procedure, the details of which have recently been reported (46). Toxin purity 
(>95%) was confirmed by LC-MS/MS and NMR spectroscopy and this material was used to 
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produce commercially available standards now distributed by the Certified Reference Materials 
Program at the National Research Council of Canada (Inst. for Marine Biosciences, Halifax, NS, 
Canada). Toxin dilutions prior to cell exposure were performed in phosphate-buffered saline 
(PBS; pH 7.4)/10% methanol. Toxin/methanol additions never exceeded 1% vol/vol. 
 
Cell Culturing. Human Jurkat E6-1 T lymphocyte cells (American Type Culture Collection 
TIB-152; Manassas, VA, USA) were grown as described in Twiner et al. (24). Briefly, cells were 
grown in RPMI medium (cat. #11875-093, Invitrogen, CA, USA) supplemented with 10% (v/v) 
fetal bovine serum (FBS; cat. #26140, Invitrogen, CA, USA) and maintained in a humidified 
incubator (Sanyo 18AIC-UV) with 5%:95% CO2:air at 37 oC. Cells were subcultured with fresh 
medium at an inoculum ratio of 1:4 every 3 to 4 days by transferring 2.5 mL of cells to 7.5 mL of 
fresh supplemented medium in 75 cm2 screw cap culture flasks. 
 
Cytotoxicity assay. T lymphocytes were diluted in fresh medium to 3-4 x 105 cells/mL and 
seeded in 96-well plates containing 100 µL per well (3-4 x 104 cells/well). Cells were allowed to 
settle for 18-24 h prior to AZA additions to each set of three replicate wells for 24, 48, or 72 h of 
continuous exposure. The final concentration of AZA1 ranged from 9.48 x 10-8 to 1 x 10-12 M 
and the final concentrations of AZA2 and AZA3 ranged from 1.5 x 10-8 to 5 x 10-12 M. Vehicle 
control wells with an equivalent amount of 10% methanol in PBS were used to normalize the 
viability data.  Cellular viability/cytotoxicity was assessed using the MTS assay (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; cat. no. 
G358A, Promega Biosciences, CA, USA). Absorbance of each well was measured at 485 nm 
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using a Fluostar microplate reader (BMG Technologies, NC, USA). All data (mean ± SE) from 3 
or more separate experiments were normalized to percentage relative to vehicle controls.  
 
Morphological characteristics. T lymphocytes were diluted in fresh medium to 3-4 x 105 
cells/mL and seeded in 24-well plates containing 500 µL per well (1.5-2 x 105 cells/well). Cells 
were exposed to AZA concentrations approximately twice the EC50 concentration (Table 1 and 
Figure 2). Final concentrations were 5 x 10-9 M AZA1, 5 x 10-10 M AZA2, and 1 x 10-9 M 
AZA3. Vehicle control wells contained an equivalent amount of 10% methanol in PBS. Cells 
were continuously exposed for 24, 48, or 72 h prior to microscopic examination and imaging. 
Differential interference contrast (DIC) and epi-fluorescence photomicrographs were taken using 
an Axioskop 50 microscope (Carl Zeiss, Inc., Thornwood, NY, USA). DIC images were taken 
directly using aliquots of suspended cells. Epi-fluorescence images of intracellular actin were 
obtained by preparing the cells as described in Twiner et al. (2005) and staining with Alexa Fluor 
Phalloidin (cat. #12379, Invitrogen, CA, USA). Images were captured using a Canon EOS 5D 
(EF 24-105 L IS USM) camera.  
 
Statistical Analysis. Data are presented as means ± SE of at least three separate experiments. 
In addition, each cytotoxicity experiment was performed using triplicate wells.  Cytotoxicity data 
were blank corrected and normalized to the vehicle control (% viability). EC50 and 95% 
confidence interval determinations were calculated using three parameter, variable slope, non-
linear regression analysis (GraphPad Prism, ver. 5.0c, San Diego, USA).  
 
RESULTS 
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Effect of AZA Analogs on Cell Viability. Jurkat T lymphocyte cells were exposed to natural 
analogs of AZA (i.e., AZA1, AZA2, AZA3) to assess cellular viability and determine relative 
potencies. AZAs were tested across a range of concentrations and time points (24, 48, and 72 h). 
Each AZA analog induced time- and concentration-dependent cytotoxicity to the lymphocyte 
cells (Figure 2) but differed in their relative potencies. Cytotoxicity was minimal at 24 h with 
cell viability ranging from 78%-86% for the three AZA analogs. Longer exposure times of 48 
and 72 h for each AZA analog resulted in a step-wise reduction of viability causing more 
complete cytotoxicity (20-21% viability at 48 h and 7-12% viability at 72 h) at AZA1 
concentrations > 1 nM, AZA2 concentrations > 0.1 nM, and AZA3 concentrations > 0.5 nM. 
EC50 values (including 95% confidence intervals) are presented for each AZA analog at each 
time point in Table 1. The mean EC50 value for each AZA analog across all three time points was 
2.5 nM for AZA1, 0.30 nM for AZA2, and 0.55 nM for AZA3. As such, AZA2 and AZA3 were 
8.3-fold and 4.5-fold more potent than AZA1, respectively (Table 1).  
 
Morphological Changes of Lymphocyte Cells Following Exposure to AZA Analogs. 
Photomicrographs of control T lymphocyte cells illustrated that they were clearly intact with no 
signs of lysis and exhibited cytosolic extensions that have been identified as pseudopodia or 
“false feet” (Figure 3A, B, and C; see arrows).  However, lymphocyte cells exposed to the AZA 
analogs suggest a variety of cytolytic effects. Cells exposed to 5 nM AZA1 displayed a lack of 
cellular integrity (particularly at 48 and 72 h) as revealed by lysed cells and debris, organelle 
protrusion with concurrent flattening of cells, and a distinct lack of pseudopodia (Figure 3D, E, 
and F). Although cell diameter was significantly (p < 0.05) increased at 72 h, this appears to be 
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an artifact related to the flattening of the cells during cytolysis and not due to cellular swelling or 
blebbing.  
Cells treated with AZA2 and AZA3 also showed time-dependent cytolysis with some features 
(i.e., lack of cellular integrity, organelle protrusion, flattening of cells) in common with AZA1-
treated cells (Figure 3G, H, I, and Figure 3J, K, L, respectively). However, despite clear 
cytolysis, pseudopodia were still present in each of these treatment regimes (as indicated by 
arrows). Apparent increases in cell diameter were also statistically significant (p < 0.05) for 
AZA2 at 72 h and AZA3 at 48 and 72 h (data not shown), but similar to AZA1 these changes are 
attributed to cell flattening and not actual swelling.  
 
Effects of AZA Analogs on Arrangement of F-actin. Photomicrographs of fluorescently 
stained control cells illustrate their spheroid-like shape with irregular, F-actin filled pseudopodial 
extensions (Figure 4A, B, and C). Upon exposure to AZA1 for 24, 48, or 72 h, cells became 
more rounded with a loss of pseudopodial extensions (Figure 4D, E, and F, respectively). Lysed 
or lysing cells were not apparent, likely due to the loss of exuded material or debris during the 
staining procedure. Cells exposed to AZA2 and AZA3 for 24, 48, or 72 h looked remarkably 
similar to control cells with respect to the continued presence of pseudopodia (Figure 4G, H, I, 
and Figure 4J, K, L, respectively). Similarly, the presence of cells undergoing lysis was not 
expected due to the staining procedure.  
 
Quantitative Effects of AZA Analogs on Pseudopodia. Jurkat T lymphocyte cells were 
exposed to AZA1 across a range of concentrations for 48 h prior to enumeration of pseudopodial 
extensions. AZA1 caused a concentration-dependent reduction in visible pseudopodia per cell 
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with an IC50 value of 0.68 nM (0.54 - 0.84 nM 95% confidence internals) (Figure 5). Control 
cells consistently had visible pseudopodia (mean = 2.1 ± 0.18; n = 50 cells), whereas cells treated 
with ≥ 10 nM AZA1 had no discernible pseudopodia. When cells were treated for 48 h with 
AZA2 or AZA3 under the same conditions outlined in Figures 3 and 4 (0.5 nM AZA2 and 1 nM 
AZA3), there was an average of 2.2 ± 0.19 and 2.1 ± 0.17 (n = 50) visible pseudopodia per cell, 
respectively (Figure 6). 
 
 
DISCUSSION 
Human AZA shellfish poisonings have now been reported in multiple European countries and 
in the United States, caused by the import of contaminated Irish shellfish (2, 3). Although more 
than 20 AZA analogs have been identified, only three (AZA1, AZA2, and AZA3) are currently 
thought to be of toxicological concern and as such are regulated in European seafood products at 
a maximal level of 0.16 µg AZAtotal/g shellfish meat (23). The determination of AZAtotal (i.e., 
AZA1, AZA2, and AZA3) is primarily performed via LC-MS/MS quantification and the 
application of toxic equivalence factors (TEFs) to account for potency differences between the 
AZA analogs. Based on mouse intraperitoneal injections, TEFs of 1.0, 1.8, and 1.4 are currently 
employed for AZA1, AZA2, and AZA3, respectively (21, 47), thereby implying that the in vivo 
order of potency is AZA2 > AZA3 > AZA1. Our focus herein was to compare these in vivo 
findings with in vitro cytotoxicity-based data, as well as assess the morphological effects of 
AZAs in a T lymphocyte model cell line as a means to better understand their potential toxic 
effects. 
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The cytotoxic potential of AZA1 towards various cell types is well established and has been 
unambiguously demonstrated using microscopy techniques (24, 27, 34, 39), cellular protein 
content (27), DNA content and synthesis (27, 48), release of cytosolic enzymes (31, 36), and 
mitochondrial activity (24, 31). Within the current study, the cytotoxic potential of AZA1, as 
well as AZA2 and AZA3, was confirmed using human Jurkat T lymphocytes as the model cell 
line, selected based on previous work demonstrating its high level of sensitivity to AZA1 (28). 
Each analog induced cytotoxicity in a time- and concentration-dependent manner, exhibiting 
EC50 concentrations in the sub- to low-nanomolar (0.25 – 2.7 nM) range, which are remarkably 
lower (i.e., more potent) than the EC50 values for these same AZA analogs tested against murine 
neocortical neurons (42.7, 48.0, and 9.88 nM for AZA1, AZA2, and AZA3, respectively) (31), 
but very similar to AZA2 studies using murine lymphoblast cells (EC50 = 0.84 nM) (6). 
Consistent with previous AZA1 studies, increased exposure time to the AZA analogs did affect 
cell viability but it did not change the calculated EC50 values for time points up to 72 h (24). 
Based on EC50 values for each analog, AZA2 and AZA3 are 8.3-fold and 4.5-fold more potent 
than AZA1, suggesting the order of in vitro potency as AZA2 > AZA3 > AZA1. This order is 
consistent with the corresponding in vivo results reported by Satake et al. (47) and Ofuji et al. 
(21) (based on minimal lethal concentrations) that have been implemented by the EU for 
regulatory purposes (23). However, the TEFs estimated based on these in vivo studies (23) 
suggest less drastic potency differences between these three AZA analogs as compared to the in 
vitro data. In contrast, the relative cytotoxic potencies of these same AZA analogs differ when 
assessed in neocortical neurons (i.e., AZA3 > AZA2 ~ AZA1) and by cytotoxicity (via LDH 
release) and calcium ion oscillation suppression (31) (i.e., AZA3 > AZA2 > AZA1), further 
supporting cell type differences in sensitivity. As such, methylation at C8 (AZA2) confers the 
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highest degree of cytotoxic potency in T lymphocytes, whereas de-methylation at C22 (AZA3) 
confers the highest degree of potency in neocortical neurons, suggesting that structural changes 
in analogs yield variable toxicities in different cell lines.  
An interesting and rather unusual observation compared to other phycotoxin classes is that the 
various AZA analogs showing structural differences at the C3, C8, C22, and/or the C23 
positions, elicit different cellular effects and in turn, may be affecting more than one molecular 
target. This was suspected early on by the Botana group when studying secondary messenger 
systems (28, 29, 38, 41) and also reported more recently by the Murray group when they 
observed a discrepancy between the effects of AZA1 and fragments of AZA1 on cytotoxicity and 
spontaneous calcium ion oscillations (31). We have documented previously the total retraction of 
pseudopodia in T lymphocyte cells caused by AZA1 in a time-dependent manner that was 
specific to AZA1 but not elicited by a wide variety of other marine phycotoxins (24). In the 
present study, AZA1 caused similar retraction of pseudopodia in a concentration-dependent 
manner with no observed effect on ruffle formation. On the contrary, exposure of T lymphocyte 
cells to AZA2 and AZA3 had no effect on morphological characteristics or number of 
pseudopodia. The mechanisms involved in pseudopodia assembly are not completely understood 
but they are known to involve nucleation of actin filaments by nucleation factors such as formin 
proteins (49). Despite evidence that AZA1 does not directly alter actin polymerization and/or 
depolymerization (7), actin nucleation factors such as formin FRL2 have been shown to be 
directly involved in the formation and length of pseudopodia in Jurkat T lymphocyte cells (50), 
and may be affected by AZA1. The functional relevance of pseudopodia inhibition by AZA1 has 
not yet been examined but may compromise immune function in organisms exposed to AZAs.  
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With the possibility of multiple targets, discerning the structure-activity relationships (SAR) of 
AZAs becomes very complex. Although varying in toxic potency, AZA1, AZA2, AZA3, AZA4 
and AZA5 are lethal to mice following i.p. injection (21, 22, 47) and AZA1, AZA2, and AZA3 
have been shown to be highly cytotoxic in vitro (6, 24, 25, 31). Prior to the recent availability of 
other natural AZA analogs, SAR studies have benefited tremendously from the in silico organic 
synthesis of AZA1 (44) and the use of various fragments produced during this process. AZA1 
fragments containing the ABCD/ABCDE rings yielded increased cytosolic calcium ion 
concentrations without affecting viability in murine cerebellar granule cells (CGCs) (25). These 
fragments also did not affect the growth of a lung carcinoma cell line, nor the morphology and 
cytoskeletal features of a neuroblastoma cell line (27). The same ABCD/ABCDE fragments 
tested against neocortical neurons did not elicit any effects on calcium ion oscillations or cellular 
viability (31). SAR studies using the FGHI rings revealed no effects on cytosolic calcium ion 
concentrations or viability in CGCs (25), yet inhibited calcium ion oscillations and reduced 
cellular viability in neocortical neurons (31). The relative potencies were particularly high for the 
FGHI rings when attached to a phenyl glycine methyl ester moiety, a functional component of 
the natural AZA1, AZA2, and AZA3 analogs. On the contrary, the same set of fragments 
provided by Nicolaou et al. and applied in vivo suggested that the full AZA structure, with its 
correct stereochemistry, is necessary to induce lethality at levels similar to the natural analog 
(40). 
Many of these differences in SAR observations may be due to the respective model cell 
lines/organisms employed, coupled with the possibility of multiple molecular targets among the 
AZA toxin class. The existence of distinct molecular targets may also help explain the 
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simultaneous appearance of cellular markers for both apoptosis and necrosis across a variety of 
cell lines (7, 31, 38, 39) and following in vivo exposure (17, 18).  
 
CONCLUSIONS 
Our data provide evidence that AZA1, AZA2, and AZA3 are highly cytotoxic to T 
lymphocytes and that there are significant differences in their relative potencies that correlate 
well with in vivo studies. Furthermore, specific cellular effects such as pseudopodial retraction 
are not conserved across all analogs within this toxin class, but thus far are only observed for 
AZA1. Collectively, our data support the growing body of evidence suggesting that there may be 
several molecular targets for the AZAs and it is likely that these are differentially affected by the 
various AZA analogs.   
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Tables and Figures Legends 
 
 
Table 1. Cytotoxicity EC50 values (nM) and 95% confidence intervals for AZA1, AZA2, and 
AZA3. 
                        
AZA 
analog 
24 h  48 h  72 h  Mean 
EC50 
Rel. 
Pot. EC50 95% CI  EC50 95% CI  EC50 95% CI  
AZA-1 2.1 0.56 - 8.3  2.7 1.2  -  6.2  2.6 1.4  -  4.9  2.5 1.0 
AZA-2 0.38 0.10 - 1.4  0.28    0.15 - 0.52  0.25 0.14 - 0.43  0.30 8.3 
AZA-3 0.44 0.15 - 1.3  0.58 0.29 - 1.2  0.63 0.32 - 1.2  0.55 4.5 
            
 
 
 
 
Figure Legends 
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Figure 1. Chemical structures of AZA1, AZA2, and AZA3. 
 
Figure 2. Effect of various AZA analogs on cell viability. Lymphocyte T cells were exposed to 
AZA1, AZA2, or AZA3 for 24, 48, or 72 h and viability was assessed using the MTS assay. All 
data (mean ± SE; n ≥ 3) were normalized to the control (methanol vehicle) and analyzed using 
non-linear sigmoidal dose-response (variable slope). Calculated EC50 values are shown in Table 
1. 
 
Figure 3. Effect of various AZA analogs on cell morphology. Jurkat T lymphocyte cells were 
exposed to AZA analogs at ca. twice EC50 concentrations for 24, 48, and 72 h (from left to right) 
prior to photographs being taken.  Panels A, B, and C illustrate control cells exposed to 
equivalent volumes of methanol, panels D, E, and F illustrate cells exposed to 5 nM AZA1, 
panels G, H, and I illustrate cells exposed to 0.5 nM AZA2, and panels J, K, and L illustrate cells 
exposed to 1 nM AZA3. Arrows indicate the location of pseudopodia. Note: Each panel is a 
composite of various individual DIC images/cells and not a single field of view, thus illustrating 
a representative range of cell morphologies.  
 
Figure 4. Fluorescence staining and visualization of F-actin in Jurkat T lymphocyte cells 
following exposure to various AZA analogs.   Jurkat T lymphocyte cells were exposed to AZA 
analogs at ca. twice EC50 concentrations for 24, 48, and 72 h (from left to right) prior to 
fluorescent staining and visualizing cellular F-actin using Alexa Fluor 488 phalloidin. Panels A, 
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B, and C illustrate control cells exposed to equivalent volumes of methanol, panels D, E, and F 
illustrate cells exposed to 5 nM AZA1, panels G, H, and I illustrate cells exposed to 0.5 nM 
AZA2, and panels J, K, and L illustrate cells exposed to 1 nM AZA3. Arrows indicate the 
location of pseudopodia. Note: Each panel is a composite of various individual epi-fluorescence 
images/cells and not a single field of view, thus illustrating a representative range of cell 
morphologies.  
 
Figure 5. Effect of AZA1 on the abundance of pseudopodia. Lymphocyte T cells were exposed 
to various concentrations of AZA1 for 48 h and the number of pseudopodia per cell were 
counted using DIC microscopy. All data (mean ± SE; n = 50 individual cells) were analyzed 
using non-linear sigmoidal dose-response (variable slope). 
 
 
 
Figure 6. Effects of various AZA analogs on the abundance of pseudopodia. Lymphocyte T cells 
were exposed to AZA1 (5 nM), AZA2 (0.5 nM), or AZA3 (1 nM) for 48 h and the number of 
pseudopodia per cell were counted using DIC microscopy. Data are illustrated as mean ± SE (n = 
50 individual cells) and an asterisk (*) indicates a significant difference from vehicle control (p < 
0.05). 
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